Jerusalem Pharmaceuticals Co. Ltd. (PEX: JPH)

Jerusalem Pharmaceuticals Revenue

Jerusalem Pharmaceuticals had revenue of $8.68M USD in the quarter ending June 30, 2024, a decrease of -6.97%. This brings the company's revenue in the last twelve months to $37.50M, down -14.71% year-over-year. In the year 2023, Jerusalem Pharmaceuticals had annual revenue of $39.65M, down -14.06%.

• Revenue (ttm): $37.50M
• Revenue Growth: -14.71%
• P/S Ratio: 1.73
• Revenue / Employee: $71.71K
• Employees: 523
• Market Cap: 45.91M JOD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	39.65M	-6.49M	-14.06%
Dec 31, 2022	46.14M	-82.72K	-0.18%
Dec 31, 2021	46.23M	9.83M	27.00%
Dec 31, 2020	36.40M	2.31M	6.77%
Dec 31, 2019	34.09M	3.29M	10.67%